KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 107 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $491,554 | +36.3% | 28,299 | +10.5% | 0.00% | – |
Q2 2023 | $360,729 | +31.2% | 25,620 | +0.2% | 0.00% | – |
Q1 2023 | $275,000 | +92492.6% | 25,561 | +28.9% | 0.00% | – |
Q4 2022 | $297 | -99.9% | 19,825 | +2.8% | 0.00% | – |
Q3 2022 | $248,000 | +41.7% | 19,288 | +6.1% | 0.00% | – |
Q2 2022 | $175,000 | -1.1% | 18,173 | +2.0% | 0.00% | – |
Q1 2022 | $177,000 | +4.7% | 17,825 | +23.8% | 0.00% | – |
Q4 2021 | $169,000 | +13.4% | 14,394 | +9.3% | 0.00% | – |
Q3 2021 | $149,000 | -16.3% | 13,167 | +3.2% | 0.00% | – |
Q2 2021 | $178,000 | -4.8% | 12,756 | +26.6% | 0.00% | – |
Q1 2021 | $187,000 | -11.0% | 10,073 | -15.2% | 0.00% | – |
Q4 2020 | $210,000 | +35.5% | 11,885 | +19.3% | 0.00% | – |
Q3 2020 | $155,000 | -4.9% | 9,965 | +55.3% | 0.00% | – |
Q2 2020 | $163,000 | +19.0% | 6,415 | -27.9% | 0.00% | – |
Q1 2020 | $137,000 | +168.6% | 8,895 | +94.2% | 0.00% | – |
Q4 2019 | $51,000 | +30.8% | 4,581 | +0.2% | 0.00% | – |
Q3 2019 | $39,000 | -25.0% | 4,574 | +19.4% | 0.00% | – |
Q2 2019 | $52,000 | 0.0% | 3,832 | +33.1% | 0.00% | – |
Q1 2019 | $52,000 | +10.6% | 2,880 | +73.7% | 0.00% | – |
Q4 2018 | $47,000 | +23.7% | 1,658 | +10.3% | 0.00% | – |
Q3 2018 | $38,000 | – | 1,503 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |